Skip to content

CareDx CDNA Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
-$54M-2,355%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's increase (decrease) in accounts receivable?
CareDx (CDNA) reported increase (decrease) in accounts receivable of $2.08M in Q1 2026.
How has CareDx's increase (decrease) in accounts receivable changed year-over-year?
CareDx's increase (decrease) in accounts receivable decreased by 68.7% year-over-year, from $6.64M to $2.08M.
What is the long-term trend for CareDx's increase (decrease) in accounts receivable?
Over 2 years (2021 to 2025), CareDx's increase (decrease) in accounts receivable has grown at a -4.0% compound annual growth rate (CAGR), from $24.42M to -$22.52M.